Volume 1, Number 12        May 10, 2006                                        BioComp Home     Dakota Home     Archives     Store

Welcome to "BioComp Investors & Traders"
A newsletter / journal for financially interested customers and friends.

 
In this issue:

  • Movie Time:  Trading WCI Communities

  • Dakota User Clocks in 80 S&P Points in 8 Weeks... That's In the Pocket

  • Dakota R/T Prepares for Beta Release

  • Dakota Price Ticks UP and Another is Coming

Movie Time: Trading WCI Communities
This security was found in the Dakota Knowledge Base, the repository of results built by Dakota users nice enough to volunteer to contribute (find *that* in another product, I double-dog dare you).  We use Dakota version 1.5 and the Momentum Bot to trade WCI Communities.  This example shows us how to make $3,769.00 in 5 years trading 100 shares.  Results are hypothetical, of course.

So, get a bowl of popcorn, pull up a chair and watch:
http://www.biocompsystems.com/products/Dakota/videos/index.htm

Back to top

Dakota User Clocks in 80 S&P Points in 8 Weeks
Now granted, the S&P has been on an uptrend, which helps, but one unnamed user reports he's gained 80 points in the pocket (not hypothetical) in March and April.  Pulling up some data, I see that the S&P 500 index was 1291 on March 1st and 1305 on May 1st, a difference of only 14 points, not 80.  The 80:14 ratio is beating the market by 570%.  Nice.  Very nice.

How did he do it?  I'm not going to say any more than it was using Dakota with "off the shelf" bots, ready and available to download today.  Better yet, this kind gentleman has his Knowledge Base participation turned ON, which means all Dakota users can see how his swarms were built.

Get the Knowledge Base... Get Dakota today!
http://www.biocompsystems.com/store/financial/index.htm

Back to top

Dakota R/T Prepares for Beta Release
Dakota R/T is the intra-day Dakota product, giving you the ability to create and use real-time adaptive trading systems for stocks, bonds, futures, currencies, commodities or numerous other securities.  Just like the end-of-day Dakota, our new Swarm TechnologyTM  provides you with self-adjusting profit-adapted market positions, but with Dakota R/T, it's during the trading day.

To get streaming quotes, Dakota R/T will interface with Medved's QuoteTracker (www.quotetracker.com) which supports a lot of streaming data providers (http://www.quotetracker.com/qsources.shtml), very likely including yours.  Why QuoteTracker?  Because it enables us to build one interface to many sources, freeing up our resources to invest into Dakota R/T rather than a lot of different data handling.  That saves both of us time and money.

The data from QuoteTracker is actually received by the new BioComp Tick Historian, which archives tick data to disk for all the tickers in your QuoteTracker portfolio and also raises "tick events" that Dakota R/T can subscribe to.  This way, the Tick Historian can be set to just run, accumulating tick data regardless if you are using Dakota R/T at the moment.

Dakota R/T's data handling enables you to process 1) the Tick Historian's historical data, 2) your own data files of bar data or 3) live streaming data.  In all cases, you can convert the data to one of 4 styles of bars: time (N seconds, minutes, hours, days, etc.), N ticks per bar, N units of volume per bar and N units of range per bar.  You can use the histories to build and evaluate swarm systems, then switch on-line to process intraday data using the same bar definitions.

Dakota R/T's user experience is similar to the end-of-day Dakota.  Our objective is to make it REALLY easy to run.  Start Dakota, chose historical or live data, choose a bar type, choose a trading bot, push Go.  As one Dakota user says, "The ease of use is scary".

Ok, you are interested... You want to get involved... Well, the beta list is full, but we will soon be opening the "Early Adopter" pricing like we've done when introducing all of our other products.  "Early Adopter" means you are willing to get involved in the early stages of the product's life cycle for a reduced investment.  Head on over to the new, draft ...

Dakota R/T Homepage

Back to top

Dakota Pricing
In the last issue, we mentioned that in the recent user survey of Dakota users they said that the price for the end-of-day standard Dakota license was too cheap.  They said it should be around $800 rather than $599.  On May 5th, we increased it by $100 to $699, but we aren't to the target $799 yet.   We will be raising it another $100 soon.  If you wish to get involved, now is still a good time.  On-line secure orders are taken here:
http://www.biocompsystems.com/store/financial/index.htm

It's a good value.  Ask the guy above who made 80 S&P points.  He'll tell you it should be around $5,000 or so [wink].

As always, long term valued customers automatically receive a Silver (10%), Gold (15%) or Platinum (25%) Preferred Customer Discount.  Not sure what level discount you receive, send an email to sales@biocompsystems.com and we'll let you know.

Back to top

Closure
If you find this newsletter interesting, please stay subscribed.  If you think others might like getting it, forward this email to them or post a link to our website in your favorite trading discussion group.  That helps us grow.  We'd appreciate it.  If you have suggestions, please email me at cmcook@biocompsystems.com.


This newsletter is brought to you by BioComp Systems, Inc.  Please forward it to anyone who might be interested.  They can also subscribe at: http://www.biocompsystems.com/cgi-bin/mojo.cgi?f=s&l=Profit

These documents are provided for informational purposes only. The information contained in this document represents the current view of BioComp Systems on the material discussed as of the date of publication.  Materials written should not be interpreted to be a commitment on the part of BioComp and BioComp cannot guarantee the accuracy of any information presented after the date of publication.   INFORMATION PROVIDED IN THIS DOCUMENT IS PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND FREEDOM FROM INFRINGEMENT. Statements of equity performance are hypothetical and have not been substantiated by records of actual trading.  Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading.  Also, since the trades have not actually been executed, the results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity.  Simulated trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. No representation is being made that any account will or is likely to achieve profits or losses similar to those mentioned.

The user assumes the entire risk as to the accuracy and the use of this document. This document may be copied and distributed subject to the following conditions: 1) The entire document must be copied without modification; 2) All copies must contain BioComp's copyright notice and any other notices provided therein; and 3) This document may not be distributed for profit.  All trademarks acknowledged.  (C) Copyright BioComp Systems, Inc. 2006.